Skip to main content
. 2017 Mar 29;7:164–180. doi: 10.1016/j.omtn.2017.03.007

Table 1.

A Number of Successful Examples of Breast Cancer Therapy with siRNAs

siRNA Targeting Identity of Protein Function of Protein Delivered by MSN Reference
EphA2 a transmembrane receptor tyrosine kinase a decrease in EphA2 expression both in vitro and in vivo, correlated with reduced migration and experimental metastasis of breast cancer cells 7
AKT1/2 serine/threonine kinase cancer progression and metastasis 133
PKN3 protein kinase N3 knockdown of PKN3 protein not only blocks metastasis but also impairs primary breast tumor growth and angiogenesis 7
FAK focal adhesion kinase cell migration and metastasis 134
VEGF receptor tyrosine kinase stimulates endothelial cell proliferation and regulates vascular permeability Yes 79
Bcl2 Bcl2 family protein predicts response to anthracycline combination Yes 135
Mcl1 Bcl2 family protein autophagy inhibition 136
Survivin inhibitor of apoptosis (IAP) family inhibits caspase activation, leading to negative regulation of apoptosis or programmed cell death Yes 101
P-gp ATP-dependent drug efflux pump decreases chemotherapy drug concentrations and chemoresistance development Yes 12
c-myc oncogene resistance development 7
BRCA tumor suppressor gene DNA repair 137, 138
EGFR receptor tyrosine kinase cell proliferation and differentiation 139
c-KIT receptor tyrosine kinase cell survival, proliferation, and differentiation 140